Skip to main content
. 2020 Jun 11;10(6):e036875. doi: 10.1136/bmjopen-2020-036875

Figure 2.

Figure 2

Survey results by sector: (A) influences on the analysis of AEs, (B) barriers to improve AE analysis, (C) opinions on current AE analysis, (D) reasons for concern with existing methods for AE analysis and (E) potential solutions for change (improving AE analysis). AE, adverse event; CI, chief investigator; CTU, clinical trials unit.